Recipharm Pharmaservices Private Limited - Company overview

Recipharm is an active private limited company registered with ROC Mumbai on 30 December 2015, about 10 years ago.

2015-12-30 Mumbai, Maharashtra Active Unlisted Active Compliant
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹100–500 Cr
▼ -3.3%
FY 2025
PROFIT / LOSS
₹25–50 Cr
▼ -38.5%
FY 2025
EBITDA
₹50–100 Cr
▼ -6.6%
FY 2025
NET WORTH
₹500–1000 Cr
▲ 20.5%
FY 2025
TOTAL ASSETS
₹100–500 Cr
▼ -38.6%
FY 2025
EMPLOYEE COUNT
1,071–1,080
OPEN CHARGES
-
-
PAID-UP CAPITAL
18.32 cr
AUTHORISED CAPITAL
658.10 cr
COMPANY AGE
10 Years 10 Months
since 2015-12-30
LAST FILING WITH ROC
2024-03-31
Last AGM: 2024-09-30
ACTIVE GST
1
Updated: 2025-03-20 16:27:31
TOTAL MONEY RAISED
₹500–1000 Cr
SATISFIED CHARGES
-
-

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Recipharm covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Low risk
77/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (61), financial health (80), director (85) and company-foundation signals.
  • Operating for 10+ years.
Compliance Score Moderate
61/100
Statutory filings, status and regulatory flags.
  • Company status is Active as per MCA.
  • Last balance sheet filed for Mar 2024 - filings look overdue.
Financial Health Score Low risk
80/100
Profitability, leverage and liquidity from filed statements.
  • Profitable in FY 2025.
  • Positive net worth.
Director Risk Score Low risk
85/100
Board strength, DIN status and churn.
  • 3 directors on the board.
  • No disqualified or deactivated DINs on the current board.
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Recipharm Company identity, industry, contact, and registration details from MCA and company records.

Recipharm is an active private limited company registered with ROC Mumbai on 30 December 2015, about 10 years ago. Its registered office is at Flat No. 502, B Wing, Building No. 48, Mumbai, Maharashtra. It was earlier known as Dagny Pharma Private Limited.

Its filings describe the main line of business as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, which made up 100% of turnover.

It has three directors: Ina Quinn, Sourish Mittra and Anita Ramgopal Borulkar. The longest-serving is Ina Quinn, on the board since 2023; the most recent to join is Anita Ramgopal Borulkar, appointed in December 2025. Nine former directors are on record; the most recent to leave was Srinivas Rao Davuluri in January 2024.

Paid-up capital is ₹18.32 crore against an authorised ₹658 crore, so most of the authorised capital has not been issued yet. The last AGM on record was on 30 September 2024, for accounts made up to 31 March 2024. Nothing newer than 2024 shows up here, so it is worth checking the MCA portal for later filings. No charges (secured loans) are registered against it.

Chemicals •••••••• •••••••• ••••••••
  • Location Flat No. 502, B Wing, Building No. 48,, Mumbai, Maharashtra - 400089
  • Website recipharm.com
LinkedIn YouTube
Name History
Legal NameRecipharm Pharmaservices Private Limited
CIN / LLPINU24230MH2015PTC440983
Company No.440983
ClassificationPrivate Limited Indian Non-Government Company
Incorporation Date2015-12-30
Date of AGM2024-09-30
Date of Balance Sheet2024-03-31
Listing StatusUnlisted
ROC CodeRoc Mumbai
PAN
LEI Number
Active ComplianceActive Compliant

Current Directors of Recipharm (3) Current board members from MCA filings, including designation and appointment details.

I
Ina Quinn
Director | Since 2023-01-05 | DIN: 09850037
S
Sourish Mittra
Additional Director | Since 2025-09-22 | DIN: 09829185
A
Anita Ramgopal Borulkar
Additional Director | Since 2025-12-03 | DIN: 11397289

Financial Performance of Recipharm Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2025
Revenue ₹100–500 Cr ▼ -3.3%
P&L ₹25–50 Cr ▼ -38.5%
EBITDA ₹50–100 Cr ▼ -6.6%
Net worth ₹500–1000 Cr ▲ 20.5%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
ManufacturingChemical and chemical products, pharmaceuticals, medicinal chemical and botanical products100

Financial Ratios of Recipharm Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

11 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of Recipharm Ownership and contribution detail from filings. Full breakdown unlocks with your report.

10 shareholder categories on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

Employees and EPFO Compliance at Recipharm EPFO establishments, contributions, and headcount history. Full records unlock with your report.

1 establishment linked

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

Monthly headcount PF contributions ECR filing status Establishment history

Employee and EPFO history require an active report plan.

Verified entity values are shown only after access is granted.

GST Compliance of Recipharm GST registrations and filing status by state. Full compliance detail unlocks with your report.

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

GSTIN registrations State-wise filing status HSN and SAC details Tax jurisdiction records

GST registrations and filing compliance require an active report plan.

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Recipharm Ratings, court records, and regulatory alerts. Full risk detail unlocks with your report.

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

Rating history Court and tribunal cases Regulatory alerts Director-linked violations

Credit ratings, litigation, and regulatory alerts require an active report plan.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Recipharm MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Recipharm Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Recipharm Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Recipharm?
MCA does not publish an "owner" field. Recipharm is run by its directors, Ina Quinn, Sourish Mittra and Anita Ramgopal Borulkar. The people who own the shares are listed in its annual return (form MGT-7), which can differ from the directors.
Who are the current board members and directors of Recipharm?
Recipharm has three current directors: Ina Quinn (since January 2023), Sourish Mittra (since September 2025) and Anita Ramgopal Borulkar (since December 2025).
What is CIN of Recipharm?
The CIN of Recipharm is U24230MH2015PTC440983. Reading it left to right: U means it is not listed, 24230 is the industry code it registered under, MH is Maharashtra, 2015 is the year it was registered, PTC is the company type and 440983 is its registration number.
When was Recipharm incorporated?
Recipharm was incorporated on 30 December 2015 with ROC Mumbai. That makes it about 10 years old.
What is the registered address of Recipharm?
The registered office on MCA records is Flat No. 502, B Wing, Building No. 48, Mumbai, Maharashtra - 400089.
What is the current status of Recipharm?
MCA shows Recipharm as Active, and its last AGM on record was in September 2024.
What is the contact number or email for Recipharm?
You can post to its registered office at Flat No. 502, B Wing, Building No. 48, Mumbai, Maharashtra - 400089 and use its website, https://recipharm.com.
What industry or business activity is Recipharm associated with?
Its MCA filings list the main business as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products (100% of turnover).
What is paid-up capital and authorised share capital of Recipharm?
Paid-up capital is ₹18.32 crore, a small fraction of its ₹658 crore authorised capital.
When did Recipharm last file accounts and hold an AGM?
The last AGM on record was on 30 September 2024, and the latest balance sheet is for the year ending 31 March 2024. Nothing newer than 2024 shows up, so check the MCA portal for later filings.
Where can I see charges and lenders for Recipharm?
MCA shows no charges registered against Recipharm, so no assets are pledged for a registered secured loan.
Have any directors left Recipharm?
Yes, nine former directors are on record. The most recent to leave were Srinivas Rao Davuluri (January 2024), Karan Bagaria (October 2023) and Anurag Bagaria (October 2023).
What is the turnover or revenue of Recipharm?
Based on filed financial statements, the revenue of Recipharm for FY 2025 was in the ₹100–500 Cr range. That is down 3.3% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
What is the net worth of Recipharm?
For FY 2025, the net worth of Recipharm was in the ₹500–1000 Cr range.
How can I get the financial details of Recipharm?
The latest accounts on record are for FY 2025. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
What is the official website of Recipharm?
The website on record for Recipharm is https://recipharm.com.
Which company owns recipharm.com?
recipharm.com is the website listed for Recipharm Pharmaservices Private Limited in its company records.
Recipharm - is it listed or unlisted?
Recipharm is unlisted, so its shares are not traded on a stock exchange. Its CIN starts with U for the same reason.
What is the ROC code of Recipharm?
Recipharm is registered with ROC Mumbai.
What is the company classification of Recipharm?
MCA classifies Recipharm as: Private Limited Indian Non-Government Company.
Does Recipharm have GST registrations on file?
Yes, one active GST registration is linked to Recipharm.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.